EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epidemiology of chronic kidney disease in Saudi Arabia: a secondary data analysis of national trends and global burden implications

Ahmed A. Almohammadi

Journal of The Egyptian Society of Nephrology and Transplantation · 2026-10 · 26 (4) · 287-294

DOI: 10.4103/jesnt.jesnt_38_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of The Egyptian Society of Nephrology and Transplantation, online erschienen am 20.11.2026. Verfasst von Ahmed A. Almohammadi. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objectives of this study is to analyze the epidemiological burden of chronic kidney disease (CKD) in Saudi Arabia using publicly available national and global datasets, to examine temporal trends from 1990 to 2021, and to identify implications for healthcare policy aligned with Saudi Vision 2030.

Methods

This secondary data analysis synthesized epidemiological data on CKD from the Global Burden of Disease Study 2021, annual reports of the Saudi Center for Organ Transplantation, and peer-reviewed population-based studies. Age-standardized incidence rates, mortality rates, disability-adjusted life years, and prevalence estimates were extracted and analyzed. Temporal trends were assessed using the estimated annual percentage change. Statistical significance was set at P value less than 0.05.

Results

Saudi Arabia exhibited the highest age-standardized CKD incidence rate globally at 495.8 per 100 000 (95% UI: 465.09–529.64) in 2021, representing 2.1 times the global average of 233.56 per 100 000. The age-standardized mortality rate was 79.3 per 100 000 (95% UI: 59.76–95.73), ranking second globally. National CKD prevalence was 4.76% based on laboratory data from 664 684 individuals across 13 administrative regions. End-stage renal disease patients on renal replacement therapy reached 28 769 in 2020, with a dialysis prevalence of 621 per million population. Diabetes mellitus (40%) and hypertension (38%) accounted for 78% of end-stage renal disease cases. The estimated annual percentage change for incidence was 1.58 (95% confidence interval: 1.47–1.69), indicating faster-than-global disease acceleration. The burden of CKD attributable to high BMI was the highest globally at 35.62 deaths per 100 000.

Conclusion

Saudi Arabia faces an unprecedented CKD epidemic, with the highest incidence rate globally driven by diabetes, hypertension, and obesity. Urgent implementation of comprehensive screening programs, aggressive management of metabolic risk factors, and expanded nephrology workforce development are essential to achieving Vision 2030 health objectives.

Zitieren

APA

Almohammadi, A. A. (2026). Epidemiology of chronic kidney disease in Saudi Arabia: a secondary data analysis of national trends and global burden implications. Journal of The Egyptian Society of Nephrology and Transplantation, 26(4), 287-294. https://doi.org/10.4103/jesnt.jesnt_38_25

Vancouver

Almohammadi AA. Epidemiology of chronic kidney disease in Saudi Arabia: a secondary data analysis of national trends and global burden implications. Journal of The Egyptian Society of Nephrology and Transplantation. 2026;26(4):287-294. doi:10.4103/jesnt.jesnt_38_25

BibTeX
@article{Almohammadi2026,
  author = {Almohammadi, Ahmed A.},
  title = {Epidemiology of chronic kidney disease in Saudi Arabia: a secondary data analysis of national trends and global burden implications},
  journal = {Journal of The Egyptian Society of Nephrology and Transplantation},
  year = {2026},
  volume = {26},
  number = {4},
  pages = {287--294},
  doi = {10.4103/jesnt.jesnt_38_25}
}
Kostenlos starten →